LATEST ARTICLES
MOST POPULAR
Bod Unveils Initial Schedule 3 CBD Candidate Trial Results
Australian medical cannabis company Bod Science Limited (ASX:BOD) has provided preliminary top-line results from its phase IIB clinical trial of a potential Schedule 3...
Another Study Examines Cannabis Use Among Seniors
A new study has found cannabis use is becoming more common among older adults in the USA - and it's being used mostly for...
Australia’s ANTG Inks Deal With USA’s Clever Leaves
Medical cannabis companies Australian Natural Therapeutics Group (ANTG) and Clever Leaves Holdings have signed a CBD, THC and flower supply deal.Clever Leaves is a...
Medical Cannabis In New Zealand – Battle Of The Bills
One medical cannabis bill has passed its first reading in New Zealand, while a second more contentious piece of legislation heard in NZ's Parliament...
